Pure Bioscience Debt-to-Assets Ratio Growth & History (PURE)

Pure Bioscience's debt-to-assets ratio was 0.00 for fiscal 2025.

View full Pure Bioscience company overview

Pure Bioscience annual debt-to-assets ratio history

Pure Bioscience annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-07-310.000.00
20242024-07-310.000.00
20232023-07-310.000.00
20222022-07-310.000.00
20212021-07-310.000.00
20202020-07-310.000.00
20192019-07-310.000.00
20182018-07-310.000.00
20172017-07-310.000.00
20162016-07-310.000.00
20152015-07-310.000.00
20142014-07-310.00−0.61
20132013-07-310.61

Pure Bioscience debt-to-assets ratio trends

Over the last five fiscal years, Pure Bioscience's debt-to-assets ratio increased from 0.00 to 0.00, a change of 0.00. The latest reported quarter, Q3 2026, shows 1.77.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Pure Bioscience source filings ↗

Community posts

It’s quiet here.

No posts about PURE yet. Start the conversation.

Write the first post